Member Info for Toyin

Beat me too it Elric, I wish some would engage brain first. Phat, no spin needed as Elric pointed out, housekeeping, plain and simple.

mol, you seem to major in minors. GM or EGM is irrelevant they are one and the same. Stop sweating the small stuff.

bel, it could be worth revisiting Elrics Q&A. As SA does say, "so Croda is playing their hand very close to their chest." & "the anti-ageing lysate is not the be-all and end-all; this is just the beginning of a multi-channel/product journey that has only just started." Like I have said previously, I think the enhancement's/additional activities have throw a very exciting spanner in the works.

https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-5a9

bel, I dont think there will be any news on the acquisition until after the EGM on Monday, this is obviously part of the process.

Meeting with Croda, he said to TW in BC on 17/1 that Croda are playing things close to their chest.

The multinational will not be anytime soon as they want to see we are not a one trick pony, they want multiple products.

https://youtu.be/VmxC4o_SmOk?t=199

As for leaving money on the table we dont know what the margin was, if we sell £1.2m of product and only get, for eg, 25% of that at the bottom line, would it be worth doing?

SA has always said we will keep selling the products and we are expanding into Europe so of course you will keep advertising. We also have little idea how the acquisition will fit in, until we have details its all guesswork.

Aquae, download AdblockPlus for your browser. Keeps your screen tidy.

https://adblockplus.org/

oleric, it is evidence, but not evidence which you choose to acknowledge, which is fine that's up to you. We all know which evidence you want, which we all know doesn't exist. You are just a grade a tool trying to be clever.

On Trustpilot.

Improved my acne
Having struggled with acne since my teens, I have lost count of the creams and vitamins I've tried in the hope of seeing an improvement. Eager to avoid harsh medication, Axis Biotix was recommended to me by a relative after they had seen positive results for their psoriasis. After 2 - 3 weeks, I began to notice changes. My skin is clearer and healthier than it has been in over a decade. Now, when I do have a blemish, they are fewer, smaller, surface level and even heal quicker. I have started wearing less makeup for the first time in many years and feel so much brighter.
Date of experience: September 25, 2022

I did, you start by saying clio is being a little harsh, then go on to say Stuart should buy lth’s a pint for missed targets in 2023 when we are still in January. A little harsh, don’t you think?

Aquae, which targets have been missed?

Aquae, in the Q&A with Elric SA said he believed at least one production run has been achieved on the 20,000 litre vessel so I would assume there is plenty of product to go around. Also seeing as we have seen enhancements/improved activities all the way through the scale up and we haven't heard anything to the contrary, I would suggest it is looking very good.

Disco, I would agree there will likely be a slip in revenue landing. My point being the launch is still on, Croda have scaled up engaged with customers and are good to go. Then they have to go through the process of orders coming in, manufacture, ship, payment, that sequence alone could be 4-5 months and then we get paid. So if we are to get revenue in 2023 the launch has to be imminent. Plus my belief is the slip is due to the increased activity Croda found which is a positive, so i'm not concerned. I just dont see a Sweet launch before Croda launch the lysate.

Aquae, it sounds pretty ominous!

Nick Hampton, Chief Executive at Tate & Lyle, said:

"We are delighted to announce the agreement to acquire Quantum, a leader in prebiotic dietary fibres and a business recognised for its high-quality ingredients and solutions. This acquisition significantly strengthens our fortification capabilities and expands our customer offering in key food and drink categories. FOS and GOS are highly complementary to our existing fibre portfolio and will enable us to offer a broader range of solutions to our customers . The acquisition is also very much in line with our purpose to support healthy living by improving gut health, and driving sugar and calorie reduction and fibre fortification for consumers across the world."

Regarding launch, SA has repeatedly said H1 for revenues so if there has been a change to that it must be rns'd. He's just had two meetings with Croda and everything is going extremely well. My money is on sbtx, place your bets! ;-)

Well that confirms that you haven't listened to it. Piece of advice, if you dont have the facts dont make assumptions.

Farris, did you actually listen to what he said, why is it not good?

That ship has sailed Aquae. From rns 31/3/22

The acquisition of Quantum significantly strengthens Tate & Lyle's position as a leading global player in dietary fibres, bringing a high-quality portfolio of speciality fibres, strong R&D capabilities and proprietary manufacturing processes and technologies. The acquisition expands Tate & Lyle's ability to provide added-fibre solutions for its customers across a range of categories including dairy, beverages, bakery and nutrition (including infant nutrition), and to meet growing consumer interest in gut health. It also significantly expands Tate & Lyle's presence in China and Asia, and extends its capabilities to create solutions across food and drink utilising its leading speciality ingredient portfolio.

Lol, always wanted a ZX spectrum, just looked a lot cooler, the commodore was like a breeze block with keys stuck on it!

I have actually, commodore 64! It's probable they will issue some shares to the seller, but I cant see another placing. We shall have to wait and see. Re forecasts and profits i'm sure that will all have been done in the dd, bearing in mind both SA & Manprit are m&a experts!

Aquae, I dont disagree we have to sell ourselves in the medium term, we have Axis sales, we will soon have Croda revs and if the acquisition comes off we will have cash from that. Also we will have about 16 products that we will keep selling to the NHS & pharmacy chains etc, plus we back our ip into them which potentially gives us 32 products, plus, Axis PS, plus Acne. Along with all the other benefits SA mentions.

As the target company is profitable we could raise debt against that, part of it could be an earn out, there are many ways this can be done. Another equity raise is possible but by no means a certainty.

Personally if they pull it off, I will be thrilled.

Aquae, you need to read Elric's Q&A with SA again.

"For example, they have topical treatments for Acne, eczema, Psoriasis, etc. This strategic acquisition opens many doors, not least it makes us more attractive to the multinationals we are in discussions with, not least because we will have a broader topical portfolio of products we can back our science and IP into and develop new ranges or improve on them as we build our IP and science. This is precisely what the multinationals are looking for. So, it’s a big step for us."

https://lemminginvestor.substack.com/p/skinbiotherapeutics-plc-5a9

Also, who says there will be another equity raise?

Aquae, death and stupidity, the only two things that affect other people!